Rorγt+ innate lymphoid cells in intestinal homeostasis and immunity

Journal of Innate Immunity

Volumn 3, Issue 6, 2011, Pages 577-584

  Aparicio Domingo, Patricia ^a   Cupedo, Tom ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Host defense; Immune response; Innate lymphoid cells; Ror t; Toll like receptor

Indexed keywords

RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ADAPTIVE IMMUNITY; HOMEOSTASIS; INNATE IMMUNITY; INTESTINE INFECTION; INTESTINE MUCOSA; LYMPHOID CELL; PEYER PATCH; PRIORITY JOURNAL; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; CELL COMMUNICATION; CYTOKINES; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INTESTINAL MUCOSA; LYMPHOCYTES; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; SIGNAL TRANSDUCTION;

EID: 80054900196     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000330668     Document Type: Review

References (50)

1. Spits H, Di Santo JP: The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011;12:21-27.
2. Vivier E, Spits H, Cupedo T: Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat Rev Immunol 2009;9:229-234.
3. Kurebayashi S, Ueda E, Sakaue M, Patel DD, Medvedev A, Zhang F, Jetten AM: Retinoid-related orphan receptor gamma (Rorγ) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. PNAS 2000;97:10132-10137.
4. Sun Z, Unutmaz D, Zou YR, Sunshine MJ, Pierani A, Brenner-Morton S, Mebius RE, Littman DR: Requirement for Rorγ in thymocyte survival and lymphoid organ development. Science 2000;288:2369-2373.
5. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littman DR: An essential function for the nuclear receptor Rorγt in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004;5:64-73.
6. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishikawa S-I, Gruss P: Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 1999;397:702-706.
7. Boos MD, Yokota Y, Eberl G, Kee BL: Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of e protein activity. J Exp Med 2007;204:1119-1130.
8. Kanamori Y, Ishimaru K, Nanno M, Maki K, Ikuta K, Nariuchi H, Ishikawa H: Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7r+ Thy1+ lympho-hemopoietic progenitors develop. J Exp Med 1996;184:1449-1459.
9. Sawa S, Cherrier M, Lochner M, Satoh-Takayama N, Fehling HJ, Langa F, Di Santo JP, Eberl G: Lineage relationship analysis of Rorγt+ innate lymphoid cells. Science 2010;330:665-669.
10. van de Pavert SA, Mebius RE: New insights into the development of lymphoid tissues. Nat Rev Immunol 2010;10:664-674.
11. Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C, Diefenbach A: Ror[gamma] t and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 2009;10:83-91.
12. Luci C, Reynders A, Ivanov II, Cognet C, Chiche L, Chasson L, Hardwigsen J, Anguiano E, Banchereau J, Chaussabel D, Dalod M, Littman DR, Vivier E, Tomasello E: Influence of the transcription factor Rorγt on the development of NKp46+ cell populations in gut and skin. Nat Immunol 2009;10:75-82.
13. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP: Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008;29:958-970.
14. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, Doherty JM, Mills JC, Colonna M: A human natural killer cell subset provides an innate source of il-22 for mucosal immunity. Nature 2008;457:722-725.
15. Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, Fibbe WE, Cornelissen JJ, Spits H: Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009;10:66-74.
16. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L: Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197-223.
17. Crellin NK, Trifari S, Kaplan CD, Cupedo T, Spits H: Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J Exp Med 2010;207:281-290.
18. Kim MY, Anderson G, White A, Jenkinson E, Arlt W, Martensson IL, Erlandsson L, Lane PJ: OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression. J Immunol 2005;174:6686-6691.
19. Satoh-Takayama N, Lesjean-Pottier S, Vieira P, Sawa S, Eberl G, Vosshenrich CA, Di Santo JP: IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med 2010;207:273-280.
20. Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M, Bengsch B, Thimme R, Holscher C, Honig M, Pannicke U, Schwarz K, Ware CF, Finke D, Diefenbach A: Regulated expression of nuclear receptor Rorγt confers distinct functional fates to NK cell receptor-expressing Rorγt(+) innate lymphocytes. Immunity 2010;33:736-751.
21. Crellin NK, Trifari S, Kaplan CD, Satoh-Takayama N, Di Santo JP, Spits H: Regulation of cytokine secretion in human CD127(+) lti-like innate lymphoid cells by toll-like receptor 2. Immunity 2010;33:752-764.
22. Mebius RE, Rennert P, Weissman IL: Developing lymph nodes collect CD4+CD3-LTβ+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997;7:493-504.
23. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov, II, Littman DR, O'Shea JJ: Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009;206:35-41.
24. Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, Berard M, Kleinschek M, Cua D, Di Santo JP, Eberl G: Rorγt(+) innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 2011;12:320-326.
25. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS: Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs. J Exp Med 1996;184:1999-2006.
26. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K: The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998;9:59-70.
27. Rennert PD, James D, Mackay F, Browning JL, Hochman PS: Lymph node genesis is induced by signaling through the lymphotoxin β receptor. Immunity 1998;9:71-79.
28. Eberl G, Lochner M: The development of intestinal lymphoid tissues at the interface of self and microbiota. Mucosal Immunol 2009;2:478-485.
29. Van den Broeck W, Derore A, Simoens P: Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in balb/canncrl mice. J Immunol Methods 2006;312:12-19.
30. Pabst R: Plasticity and heterogeneity of lymphoid organs. What are the criteria to call a lymphoid organ primary, secondary or tertiary? Immunol Lett 2007;112:1-8.
31. Mebius RE: Organogenesis of lymphoid tissues. Nat Rev Immunol 2003;3:292-303.
32. Cornes JS: Number, size, and distribution of Peyer's patches in the human small intestine: Part I. The development of Peyer's patches. Gut 1965;6:225-229.
33. Brandtzaeg P, Kiyono H, Pabst R, Russell MW: Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 2008;1:31-37.
34. Neutra MR, Frey A, Kraehenbuhl JP: Epithelial M cells: gateways for mucosal infection and immunization. Cell 1996;86:345-348.
35. Veiga-Fernandes H, Coles MC, Foster KE, Patel A, Williams A, Natarajan D, Barlow A, Pachnis V, Kioussis D: Tyrosine kinase receptor ret is a key regulator of Peyer's patch organogenesis. Nature 2007;446:547-551.
36. Adachi S, Yoshida H, Kataoka H, Nishikawa S: Three distinctive steps in Peyer's patch formation of murine embryo. Int Immunol 1997;9:507-514.
37. Hashi H, Yoshida H, Honda K, Fraser S, Kubo H, Awane M, Takabayashi A, Nakano H, Yamaoka Y, Nishikawa SI: Compartmentalization of Peyer's patch anlagen before lymphocyte entry. J Immunol 2001;166:3702-3709.
38. Eberl G, Littman DR: Thymic origin of intestinal αβ T cells revealed by fate mapping of Rorγt+ cells. Science 2004;305:248-251.
39. Tsuji M, Suzuki K, Kitamura H, Maruya M, Kinoshita K, Ivanov II, Itoh K, Littman DR, Fagarasan S: Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin a generation in the gut. Immunity 2008;29:261-271.
40. Hamada H, Hiroi T, Nishiyama Y, Takahashi H, Masunaga Y, Hachimura S, Kaminogawa S, Takahashi-Iwanaga H, Iwanaga T, Kiyono H, Yamamoto H, Ishikawa H: Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol 2002;168:57-64.
41. Bouskra D, Brezillon C, Berard M, Werts C, Varona R, Boneca IG, Eberl G: Lymphoid tissue genesis induced by commensals through Nod1 regulates intestinal homeostasis. Nature 2008;456:507-510.
42. Aloisi F, Pujol-Borrell R: Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006;6:205-217.
43. Lochner M, Ohnmacht C, Presley L, Bruhns P, Si-Tahar M, Sawa S, Eberl G: Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RorγT and LTi cells. J Exp Med 2011;208:125-134.
44. Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D: CD4(+) lymphoid tissueinducer cells promote innate immunity in the gut. Immunity 2010;34:122-134.
45. Wang Y, Koroleva EP, Kruglov AA, Kuprash DV, Nedospasov SA, Fu YX, Tumanov AV: Lymphotoxin β receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 2010;32:403-413.
46. Han S, Koo J, Bae J, Kim S, Baik S, Kim MY: Modulation of TNFSF expression in lymphoid tissue inducer cells by dendritic cells activated with Toll-like receptor ligands. BMB Rep 2011;44:129-134.
47. Cella M, Otero K, Colonna M: Expansion of human NK-22 cells with IL-7, IL-2, and IL-1βreveals intrinsic functional plasticity. Proc Natl Acad Sci USA 2010;107:10961-10966.
48. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W: Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008;14:282-289.
49. Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld JC, Vosshenrich CA, Di Santo JP: The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against citrobacter rodentium. J Immunol 2009;183:6579-6587.
50. Buonocore S, Ahern PP, Uhlig HH, Ivanov, II, Littman DR, Maloy KJ, Powrie F: Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010;464:1371-1375.